| Autor: |
Lau E; Brigham and Women's Hospital, Boston, Massachusetts, USA., Mazer J, Carino G |
| Jazyk: |
angličtina |
| Zdroj: |
BMJ case reports [BMJ Case Rep] 2013 Oct 14; Vol. 2013. Date of Electronic Publication: 2013 Oct 14. |
| DOI: |
10.1136/bcr-2013-201015 |
| Abstrakt: |
A 49-year-old man with chronic obstructive pulmonary disease (COPD) presented with significant tachypnoea, fevers, productive cough and increased work of breathing for the previous 4 days. Laboratory data showed elevated lactate of 3.2 mEq/L. Continuous inhaled ipratropium and albuterol nebuliser treatments were administered. Lactate levels increased to 5.5 and 3.9 mEq/L, at 6 and 12 h, respectively. No infectious source was found and the lactic acidosis cleared as the patient improved. The lactic acidosis was determined to be secondary to respiratory muscle fatigue and inhaled β-agonist therapy, two under-recognised causes of lactic acidosis in patients presenting with respiratory distress. Lactic acidosis is commonly used as a clinical marker for sepsis and shock, but in the absence of tissue hypoperfusion and severe hypoxia, alternative aetiologies for elevated levels should be sought to avoid unnecessary and potentially harmful medical interventions. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
